Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 4 of the last 4 fiscal years.
-
Tight liquidity NBB
Cash and receivables cover 39 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
Aqua Pharma Belgium from Herent, company number BE0775936850, closed financial year 2025 with a result of € 274,434 after tax. For that financial year Aqua Pharma Belgium recorded a gross margin of € 1.1 million and equity of € -89,458. Compared with financial year 2024, the result moved from € -94,613 to € 274,434. Profitable, and profit is growing. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 19, 2026.
€ -89,458
▲ € 274,434 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 274,434
▲ still € 94,613 loss in 2024
Profit after tax over the fiscal year.
€ 45,560
▼ 67% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € -99,458.
People and assets in 2025
€ 820,878
▲ 3% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 88
▼ 97% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 65,737
▼ 51% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 97,333
▲ 21% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 384,688 | € 485,089 | € 769,459 | € 1,134,592 | ▲ 47% |
| Profit after taxes | € -133,154 | € -146,124 | € -94,613 | € 274,434 | ▲ € 369,048 |
| Equity | € -123,154 | € -269,278 | € -363,892 | € -89,458 | ▲ € 274,434 |
| Total debts | € 310,908 | € 337,284 | € 554,574 | € 163,417 | ▼ 71% |
| Cash | € 36,164 | € 36,533 | € 138,707 | € 45,560 | ▼ 67% |
| Retained profit | € -133,154 | € -279,278 | € -373,892 | € -99,458 | ▲ € 274,434 |
| Bank debt | € 174,000 | € 199,000 | € 340,000 | € 0 | ▼ 100% |
| Balance sheet total | € 187,754 | € 68,006 | € 190,682 | € 73,959 | ▼ 61% |
Key figures of Aqua Pharma Belgium, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Aqua Pharma Belgium?
What happened at Aqua Pharma Belgium in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 274,434. Source: NBB ↗
- New establishment in Herent. KBO
- Elvin Bugge became a director. NBB
- Hanne Mertens became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 133,154 loss in 2022 to € 274,434 profit in 2025.
Paid € 1,478 in corporate taxes since 2022.
Best year ever: 2025, with € 274,434 profit.
A new publication or filing at Aqua Pharma Belgium? We notify you, reason included.
Follow Aqua Pharma BelgiumDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Aqua Pharma Belgium are Elvin Bugge and Hanne Mertens.
Directors
According to the 2025 annual accounts
Elvin Bugge
Bestuurder
since 2021
Hanne Mertens
Bestuurder
since 2021
Establishments
Establishment units
Physical locations of this company
Duigemhofstraat 101
3020 Herent
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 9 companies are registered at this address.
All companies at this address →DUIGEMHOF
€ 97,125 gross margin · 2025
MINDSPELLER
€ 114,348 gross margin · 2025
Mindspeller BCI
€ -20,303 gross margin · 2025
Water Treatment Systems, Faucets & More
€ 20,713 gross margin · 2025
Emweb
€ 1.2 million gross margin · 2025
+4 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
one.com Mail
Hosting
ONECOM, DK
Website info
Features
Security
Details
- Company number
- 0775.936.850
- VAT number
- BE 0775.936.850
- Registered office
- Duigemhofstraat 101, 3020 Herent
- Names & denominations
- Aqua Pharma Belgium
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 19 October 2021
- Peppol
- Active · Active since 16 Nov 2021
- Contact
- ameaure.be
- Activities · NACE
Groothandel in andere machines en werktuigen, neg
Groothandel in farmaceutische en medische artikelen
Groothandel in andere machines en werktuigen, n.e.g.
Activiteiten van holdings
Overige diensten op het gebied van informatietechnologie en computer
Markt- en opinieonderzoek
Afvalwaterafvoer
Groothandel in levende dieren, muv levend vee
+6